Target for B-cell disorders

Details for Australian Patent Application No. 2005216575 (hide)

Owner Immune System Therapeutics Ltd

Inventors Hutchinson, Andrew Tasman; Dunn, Rosanne Dorothy; Raison, Robert; Jones, Darren Ross; Asvadi, Parisa

Agent FB Rice

Pub. Number AU-B-2005216575

PCT Pub. Number WO2005/082409

Priority 60/548,118 27.02.04 US

Filing date 28 February 2005

Wipo publication date 9 September 2005

Acceptance publication date 14 April 2011

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

G01N 33/532 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Production of labelled immunochemicals

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/082409 Priority application(s): WO2005/082409

4 October 2007 Change of Name(s) of Applicant(s), Section 104

  PacMab Limited The name of the applicant has been changed to Immune System Therapeutics Ltd

14 April 2011 Application Accepted

  Published as AU-B-2005216575

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216578-Water filtration using immersed membranes

2005216574-Egg-like food product